Page last updated: 2024-09-05

adenosine 2',5'-diphosphate and dalteparin

adenosine 2',5'-diphosphate has been researched along with dalteparin in 1 studies

*Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed) [MeSH]

*Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed) [MeSH]

Compound Research Comparison

Studies
(adenosine 2',5'-diphosphate)
Trials
(adenosine 2',5'-diphosphate)
Recent Studies (post-2010)
(adenosine 2',5'-diphosphate)
Studies
(dalteparin)
Trials
(dalteparin)
Recent Studies (post-2010) (dalteparin)
29025,6651,4232,267

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heptinstall, S; May, JA; Storey, RF1

Other Studies

1 other study(ies) available for adenosine 2',5'-diphosphate and dalteparin

ArticleYear
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
    Thrombosis research, 2005, Volume: 115, Issue:4

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Aspirin; Blood Platelets; Cell Degranulation; Dalteparin; Drug Synergism; Heparin; Hirudins; Humans; In Vitro Techniques; Membrane Proteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12

2005